Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrystal Amber Regulatory News (CRS)

Share Price Information for Crystal Amber (CRS)

Share Price is delayed by 15 minutes
Get Live Data
104.00    0.00 (0.00%)
Bid:
102.00
Ask:
106.00
Spread: 4.00 (3.922%)
Market Cap: £61.92m
CRS Live PriceLast checked at - London Stock Exchange

Intraday Crystal Amber Share Chart

Form 8.3 - Northgate Plc

2 Dec 2019 13:54

Crystal Amber Fund Limited - Form 8.3 - Northgate Plc

Crystal Amber Fund Limited - Form 8.3 - Northgate Plc

PR Newswire

London, December 2

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Crystal Amber Fund Limited
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeNorthgate Plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:N/A
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure29/11/2019
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”NO

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:8,303,4916.23
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:8,303,4916.23

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
Ordinary SharesPurchase21,5703.330943

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:02/12/2019
Contact name:Nick Batiste
Telephone number*:01481 742602

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
10th Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Feb 20255:11 pmRNSForm 8.3 - De La Rue plc
6th Feb 20255:32 pmRNSTransaction in Own Shares and Total Voting Rights
6th Feb 202510:56 amRNSHolding(s) in Company
5th Feb 20255:18 pmRNSTransaction in Own Shares and Total Voting Rights
5th Feb 20255:16 pmRNSForm 8.3 - De La Rue plc - Replacement
4th Feb 20256:00 pmRNSTransaction in Own Shares and Total Voting Rights
4th Feb 202511:30 amRNSForm 8.3 - De La Rue plc
3rd Feb 20255:30 pmRNSTransaction in Own Shares and Total Voting Rights
31st Jan 20255:44 pmRNSTotal Voting Rights
31st Jan 20252:04 pmRNSHolding(s) in Company
30th Jan 20255:43 pmRNSForm 8.3 - De La Rue plc
30th Jan 20255:41 pmRNSTransaction in Own Shares and Total Voting Rights
30th Jan 20258:52 amRNSForm 8.3 - De La Rue plc
30th Jan 20257:27 amRNSTransaction in Own Shares and Total Voting Rights
29th Jan 20257:00 amRNSShare Buyback Programme
28th Jan 20256:24 pmRNSTransaction in Own Shares and Total Voting Rights
28th Jan 20255:28 pmRNSForm 8.3 - De La Rue plc
28th Jan 20259:45 amRNSTransaction in Own Shares and TVR - Replacement
28th Jan 20259:45 amRNSTransaction in Own Shares and TVR - Replacement
28th Jan 20258:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Jan 20254:56 pmRNSTransaction in Own Shares and Total Voting Rights
23rd Jan 20252:10 pmRNSMonthly Net Asset Value
21st Jan 20257:00 amRNSForm 8.3 - De La Rue plc
20th Jan 20254:57 pmRNSTransaction in Own Shares and Total Voting Rights
20th Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Jan 20257:00 amRNSForm 8.3 - De La Rue plc
17th Jan 20257:00 amRNSForm 8.3 - De La Rue plc
16th Jan 202511:00 amRNSForm 8.3 - De La Rue plc
15th Jan 20255:45 pmRNSTransaction in Own Shares and Total Voting Rights
13th Jan 20256:23 pmRNSConversion of loan notes in Morphic - Replacement
13th Jan 20257:00 amRNSConversion of loan notes in Morphic Medical Inc.
9th Jan 20255:46 pmRNSTransaction in Own Shares and Total Voting Rights
8th Jan 202510:45 amRNSForm 8.3 - De La Rue plc
27th Dec 20247:00 amRNSForm 8.3 - De La Rue plc
19th Dec 202412:00 pmRNSMonthly Net Asset Value
13th Dec 202410:58 amRNSResult of AGM
3rd Dec 20247:00 amRNSFurther investment into Morphic Medical Inc
19th Nov 20244:50 pmRNSMonthly Net Asset Value
18th Nov 20242:58 pmRNSMonthly Net Asset Value
13th Nov 20247:00 amRNSPosting of Annual Report and Notice of AGM
12th Nov 20247:00 amRNSFinal Results
28th Oct 20242:23 pmRNSResult of Extraordinary General Meeting
9th Oct 20247:00 amRNSProposed B share scheme and notice of GM
1st Oct 20241:24 pmRNSMonthly Net Asset Value
11th Sep 20241:11 pmRNSMonthly Net Asset Value
30th Aug 20245:30 pmRNSTotal Voting Rights
23rd Aug 20249:04 amRNSHolding(s) in Company
20th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Aug 20244:01 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.